$141.75 arrow  Change: -5.91 %Chge: -4.00% Vol: 588,444
End Of Day Prices
High: 148.72 | Low: 141.62 | Open: 148.72 | Close: 141.75
52 Wk High: 148.72 | 52 Wk Low: 111 | Todays Pivot: 144.03
Sector: Healthcare and Pharmaceuticals add stock to watch list

Johnson & Johnson Company Profile

Johnson & Johnson (JNJ) is a large cap multinational corporation trading on NYSE, part of the health care sector. The company is divided into three major divisions: consumer healthcare, medical devices and pharmaceuticals. Johnson & Johnson (JNJ) manages 250 operating companies and franchises in 60 countries and is the second largest manufacturer of health care products. This company owns the Tylenol, Band-Aid and Neutrogena brands. Employing 115,500 people, the largest

» Read More About Johnson & Johnson

JNJ Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

St Jude Med 58.68 green arrow 48,528
Hill Rom Hldgs 76.84 green arrow 24,079
United Therapeutics Del 52.45 green arrow 49,387
Humana 179.47 red arrow 36,065
Intuitive Surgical 434.97 green arrow 52,313
Gilead Sciences 72.25 green arrow 2,376,525
Steris 64.44 red arrow 110,010
Bard C R 151.44 green arrow 22,764

Above is a small selection of related companies to Johnson & Johnson which compete alongside JNJ within the Healthcare and Pharmaceuticals sector. To see more related companies to JNJ, view our stock market today information page.

Online News For Johnson & Johnson

J&J (JNJ) Beats on Q4 Earnings, Misses Sales, Shares Up

Johnson & Johnson JNJ, the bellwether of healthcare companies, has a strong presence in the pharmaceutical, medical devices and consumer care markets across the world. This New Jersey-based company is well known for its baby-care products and brands like ...

J&J (JNJ) Q4 Earnings Top, Pharma Sales Continue to Improve

Johnson & Johnson (JNJ - Free Report) reported mixed fourth-quarter 2017 results, beating the Zacks Consensus Estimate for earnings while slightly missing the same for sales. The drug and consumer products giant issued a decent outlook for 2018. Shares ...

Calculating The Intrinsic Value Of Johnson & Johnson (NYSE:JNJ)

How far off is Johnson & Johnson (NYSE:JNJ) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock is fairly priced using the discounted cash flows (DCF) model. Anyone interested in learning a bit ...

Johnson & Johnson (JNJ) Holding Held by Natixis

The institutional investor held 54,832 shares of the capital goods company at the end of 2017Q3, valued at $6.84 million, up from 36,011 at the end of the previous reported quarter. On Monday, Shares of Johnson & Johnson (NYSE: JNJ) expressed a change of ...

Hedge Funds Now Own 67.9% Of Johnson & Johnson (JNJ)

Johnson & Johnson has had 2 insider trades in the last 3 months, including 0 open market buys and 2 sells. The institutional investor held 388,324 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $50.49M, up from 374,824 at the ...

Want To Add This Quote To Your Site?

With our stock widgets you can add a Johnson & Johnson quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for JNJ to choose from. Visit here to build your stock quote widget »